Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS

FDA

How Might the FDA Evolve Under RFK Jr. and Makary?

Ahead of Robert F. Kennedy Jr.’s confirmation hearings, experts—and RFK’s own family—expressed concerns about his vaccine-related views, though the same experts are largely unfazed by the level of power he and Marty Makary could ultimately wield over the FDA.

January 29, 2025

7 min read

Heather McKenzie

GLP-1 injector pens and pills against colorful background

Weight loss

BioAge Drops Lead Obesity Asset Months After IPO

It’s been a rocky few months for BioAge Labs, which shuttered a Phase II trial of its lead candidate azelaprag Tuesday after the molecule caused liver-based side effects.

January 28, 2025

1 min read

Dan Samorodnitsky

Man feeling stressed tired suffering from depression fatigue social anxiety

Psychedelics

Atai Touts Positive Data for Psychedelic Therapy in Alcohol Use Disorder

The results, which come on the heels of the FDA’s approval of J&J’s esketamine nasal spray Spravato as a monotherapy for treatment-resistant depression, could serve to further bolster a space hit hard by the rejection of Lykos’ MDMA-based PTSD therapy in August 2024.

January 28, 2025

2 min read

Heather McKenzie

Illustration of a group of businessmen white-collar workers dismissed

Layoffs

Atara to Cut Half Its Workforce Following FDA-Related Setbacks

Atara Biotherapeutics’ layoffs could leave the biotech with around 80 employees. The cuts follow news that the FDA rejected Ebvallo, a T cell therapy approved in Europe for a transplant-related blood cancer, and placed a clinical hold on the company’s active drug applications.

January 28, 2025

1 min read

Angela Gabriel

Illustration showing businessman pointing at chosen job candidate from among group of candidates

Job Trends

Outside Looking In: Getting a Job Still Challenging, BioSpace Report Finds

Landing a job remains challenging for life sciences professionals, according to a new BioSpace report. While 59% of surveyed organizations are actively recruiting, nearly half of unemployed survey respondents had been out of work for at least six months, and 20% of surveyed employers expect to lay off employees this year.

January 28, 2025

4 min read

Angela Gabriel

Neuroscience

Atalanta Gets $97 Million Series B to Target Neurological Disorders With RNAi

The company, co-founded by Nobel Laureate Craig Mello, aims to push molecules for Huntington’s and a form of epilepsy into Phase I trials, with additional preclinical assets targeting Parkinson’s and Alzheimer’s.

January 28, 2025

1 min read

Dan Samorodnitsky

Business and financial success concept. Modern collage with halftone hand holding a launching rocket, sales chart icons. Income growth. Successful startup. Increasing profits illustration

Startups

Versant Launches Fourth Obesity Startup Helicore to Improve Weight Loss Quality

Versant Ventures continues to invest in the increasingly competitive obesity space, this time launching Helicore with $65 million and a GIP-targeting asset intended to induce higher-quality weight loss.

January 28, 2025

2 min read

Tristan Manalac

Employer Resources

Report: 2025 Employment Outlook

In this Employment Outlook report, BioSpace explores current workforce sentiment, job activity trends and the prospective job and hiring outlook for 2025, particularly as it compares to the previous year.

January 28, 2025

1 min read

BioSpace Insights